The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 2.6
5-Year Relative Survival (Percent), 2011-2017a
By International Classification of Childhood Cancer(ICCC)b Selected Group and Subgroupc and Sex and Age
Excluding benign brain and myelodysplastic syndromes
| ICCC Group and Subgroup | Both Sexes Ages 0-19 |
Males Ages 0-19 |
Females Ages 0-19 |
Both Sexes Ages <1 |
Both Sexes Ages 1-4 |
Both Sexes Ages 5-9 |
Both Sexes Ages 10-14 |
Both Sexes Ages 15-19 |
Both Sexes Ages 0-14 |
|---|---|---|---|---|---|---|---|---|---|
| All ICCC Groups Combined | 85.1 | 84.3 | 86.0 | 79.9 | 86.6 | 85.3 | 83.5 | 85.9 | 84.7 |
| I Leukemia | 85.1 | 84.5 | 85.9 | 62.7 | 91.6 | 90.7 | 81.3 | 75.2 | 87.4 |
| I(a) Lymphoid leukemia | 89.4 | 88.6 | 90.2 | 59.3 | 94.6 | 93.2 | 85.9 | 76.0 | 91.5 |
| I(b) Acute myeloid leukemia | 67.7 | 66.9 | 68.6 | 65.3 | 71.2 | 69.1 | 64.6 | 67.2 | 67.9 |
| II Lymphomas and reticuloendothelial neo. | 94.3 | 94.3 | 94.2 | 90.2 | 94.5 | 96.8 | 93.5 | 94.0 | 94.5 |
| II(a) Hodgkin lymphoma | 97.8 | 97.7 | 97.8 | - | 100.0 | 100.0 | 97.9 | 97.4 | 98.5 |
| II(b,c,e) Non-Hodgkin lymphoma | 89.9 | 90.9 | 87.9 | - | 89.6 | 94.8 | 88.5 | 88.7 | 90.7 |
| III CNS & misc intracranial & intraspinal neo. | 74.2 | 74.7 | 73.7 | 57.7 | 76.5 | 71.3 | 77.9 | 75.8 | 73.9 |
| III(a) Ependymomas and choroid plexus tumor | 82.9 | 82.8 | 83.0 | 69.0d | 82.7 | 82.4d | 86.0d | 89.1 | 81.7 |
| III(b) Astrocytoma | 80.3 | 80.9 | 79.7 | 69.1d | 90.7 | 78.8 | 80.1 | 73.6 | 82.4 |
| III(c) Intracranial and intraspinal embryonal tumors | 67.5 | 68.1 | 66.6 | 36.1d | 61.3 | 78.4 | 74.4 | 68.2d | 67.5 |
| III(d) Other gliomas | 61.0 | 62.9 | 58.7 | - | 56.2 | 42.0 | 71.5 | 81.4 | 55.6 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 81.7 | 81.2 | 82.2 | 91.2 | 76.7 | 79.5 | 93.2 | 65.9d | 82.2 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 81.6 | 81.2 | 82.0 | 91.2 | 76.7 | 79.5 | 93.6 | - | 82.1 |
| V Retinoblastoma | 95.9 | 94.5 | 97.1 | 97.4 | 94.1 | - | - | - | 95.9 |
| VI Renal tumors | 91.4 | 89.8 | 92.7 | 87.3 | 94.0 | 92.4 | 84.6 | 79.6 | 92.3 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 93.2 | 92.7 | 93.5 | 87.1 | 94.3 | 93.9 | 89.8d | - | 93.2 |
| VII Hepatic tumors | 77.6 | 77.0 | 78.1 | 85.7 | 79.6 | 80.4d | 67.1d | 56.0d | 79.8 |
| VII(a) Hepatoblastoma | 82.4 | 81.7 | 83.2 | 85.7 | 79.6 | 91.9d | - | - | 82.1 |
| VIII Malignant bone tumors | 71.1 | 70.1 | 72.4 | - | 84.3d | 77.5 | 69.5 | 68.4 | 72.8 |
| VIII(a) Osteosarcoma | 68.1 | 65.4 | 71.6 | - | - | 75.4 | 64.8 | 68.4 | 67.8 |
| VIII(c) Ewing tumor and related sarcomas of bone | 70.3 | 72.2 | 67.4 | - | 90.1d | 76.5d | 73.1 | 59.4 | 76.3 |
| IX Soft tissue and other extraosseous sarcomas | 73.7 | 71.3 | 76.7 | 75.3 | 74.5 | 80.0 | 73.3 | 70.6 | 75.4 |
| IX(a) Rhabdomyosarcoma | 66.0 | 66.2 | 65.6 | 81.3d | 69.4 | 78.5 | 58.2 | 50.1d | 69.8 |
| X Germ cell & trophoblastic tumors & neo. of gonads | 92.0 | 92.7 | 90.8 | 84.9 | 89.0 | 96.9 | 89.6 | 93.2 | 89.5 |
| X(a) Intracranial and intraspinal germ-cell tumor | 89.4 | 90.1 | 87.4 | - | - | 95.8 | 89.8 | 92.4 | 87.7 |
| X(c) Malignant gonadal germ cell tumor | 96.0 | 96.2 | 95.5 | 92.4d | 100.0 | 100.0 | 94.2 | 95.9 | 95.9 |
| XI Other malignant epithelial neo. and melanomasf | 94.4 | 91.7 | 95.6 | - | 88.2 | 95.8 | 95.1 | 94.3 | 94.8 |
| XI(b) Thyroid carcinoma | 99.8 | 99.7 | 99.8 | - | - | 100.0 | 99.4 | 99.9 | 99.5 |
| XI(d) Malignant melanoma | 94.9 | 93.7 | 95.7 | - | 89.7d | 98.6 | 95.0 | 94.7 | 95.5 |
Footnotes:
a SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Expected survival rates are derived from life tables by socio-economic status, geography and race developed by the SEER program. Based on follow-up of patients into 2018.
b International Classification of Childhood Cancer is based on ICD-O-3. International Classification of Childhood Cancer is based on ICD-O-3. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Shin HY, Hesseling P, Stiller CA. International Incidence of Childhood Cancer, Volume III. Lyon: International Agency for Research on Cancer, In press.
c Classifications are shown for invasive cases only. For ICCC groups and subgroups that include in situ behavior, only invasive cases are shown except as noted.
d The standard error is between 5 and 10 percentage points.
e The standard error is greater than 10 percentage points.
f Includes in situ urinary bladder tumors.
- Statistic could not be calculated due to fewer than 25 cases during the time period.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.